Home/Publication/Qiming Leads US$63 Mn Bet on Hep B Treatment
Qiming Leads US$63 Mn Bet on Hep B Treatment 

22 Sep 2025

US$ 20.00

Qiming Venture Partners has co-led the US$63 m series B financing round of AusperBio. Hankang Capital, CDH Venture ......

Price / article: US$20.00
OR existing subscriber
Related Publications

Peak XV Partners (PeakXV) has led the A$2.3 m (US$1.5 m) pre-seed financing round of Australia-based Pura Link Pty Ltd...

Iron Pillar has led the US$23 m series C funding round undertaken by Chakr Innovation Pvt Ltd (Chakr) which develops...

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.